DailyDoctor Archive Specialties Get app
Back to the 10 October 2026 edition

Clinical update · 02 of 05

Acute exacerbation now defined across all fibrotic ILD, separate from other acute worsening

In acute worsening of fibrotic ILD, image for diffuse alveolar damage and exclude treatable mimics before labelling it an exacerbation.

Design
International working group report and literature review
Population
Patients with idiopathic and non-idiopathic fibrotic interstitial lung disease
Primary outcome
Revised definition and framework for acute exacerbation and acute respiratory worsening
Effect
Acute exacerbation defined by new diffuse alveolar damage in any fibrotic ILD; acute respiratory worsening as a separate category

An international working group has updated the 2016 report on acute exacerbation of idiopathic pulmonary fibrosis and extended it to all fibrotic interstitial lung diseases.

The proposed definition of acute exacerbation is an acute respiratory event with increased symptoms or signs and imaging or histological features consistent with diffuse alveolar damage, with or without organising pneumonia, in a patient with known or newly diagnosed fibrotic ILD. A separate category, acute respiratory worsening, covers deterioration not due to diffuse alveolar damage, such as pulmonary oedema, bronchitis and pneumonia — though severe pneumonia can trigger an exacerbation.

The practical value is in the work-up. A patient with fibrotic ILD who becomes acutely breathless needs high-resolution CT looking for new bilateral ground glass, and a deliberate search for heart failure, infection and pulmonary embolism. The report notes that no treatment has been proven effective for acute exacerbation, which is why distinguishing it from treatable mimics matters.

  • Arrange CT in a patient with fibrotic ILD and acute worsening, looking for new ground glass consistent with diffuse alveolar damage.
  • Look actively for heart failure, infection and pulmonary embolism, which cause acute worsening without an exacerbation.
  • Apply the same approach to non-IPF fibrotic ILD, not only IPF.
  • Discuss prognosis and goals early; acute exacerbation carries high mortality and has no proven treatment.

Why it matters

It gives one definition across fibrotic ILDs and separates exacerbation from causes that have treatments.

Read the rest in the app

You have read your two free briefings this month. The app carries all 27 specialties, every morning, free — and this finding is waiting in it.

QR code to install Daily Doctor
Get Daily Doctor — free

Scan to keep reading on your phone. No account needed to start.

asthmaild

Tomorrow morning, before your first patient

One edition a day for pulmonology, written by the desk, every claim tied to its paper. Six minutes.

Get the app — free
Daily Doctor All 27 specialties, every morning. Free.
Get the app